|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 15006 |
FusionGeneSummary for GNRHR2_S100A13 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: GNRHR2_S100A13 | Fusion gene ID: 15006 | Hgene | Tgene | Gene symbol | GNRHR2 | S100A13 | Gene ID | 114814 | 6284 |
| Gene name | gonadotropin releasing hormone receptor 2 (pseudogene) | S100 calcium binding protein A13 | |
| Synonyms | GnRH-II-R | - | |
| Cytomap | 1q21.1 | 1q21.3 | |
| Type of gene | pseudo | protein-coding | |
| Description | GnRH receptor II 5TMType II GnRH receptorgonadotropin-releasing hormone (type 2) receptor 2, pseudogene | protein S100-A13 | |
| Modification date | 20180523 | 20180522 | |
| UniProtAcc | Q99584 | ||
| Ensembl transtripts involved in fusion gene | ENST00000312753, | ENST00000339556, ENST00000392622, ENST00000392623, ENST00000440685, ENST00000368699, ENST00000491177, | |
| Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 7 X 7 X 4=196 |
| # samples | 1 | 8 | |
| ** MAII score | log2(1/1*10)=3.32192809488736 | log2(8/196*10)=-1.29278174922785 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: GNRHR2 [Title/Abstract] AND S100A13 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | S100A13 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 15033494 |
| Tgene | S100A13 | GO:0050703 | interleukin-1 alpha secretion | 12746488 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | HNSC | TCGA-TN-A7HJ-01A | GNRHR2 | chr1 | 145515189 | - | S100A13 | chr1 | 153591514 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5UTR-3CDS | ENST00000312753 | ENST00000339556 | GNRHR2 | chr1 | 145515189 | - | S100A13 | chr1 | 153591514 | - |
| 5UTR-3CDS | ENST00000312753 | ENST00000392622 | GNRHR2 | chr1 | 145515189 | - | S100A13 | chr1 | 153591514 | - |
| 5UTR-3CDS | ENST00000312753 | ENST00000392623 | GNRHR2 | chr1 | 145515189 | - | S100A13 | chr1 | 153591514 | - |
| 5UTR-3CDS | ENST00000312753 | ENST00000440685 | GNRHR2 | chr1 | 145515189 | - | S100A13 | chr1 | 153591514 | - |
| 5UTR-3CDS | ENST00000312753 | ENST00000368699 | GNRHR2 | chr1 | 145515189 | - | S100A13 | chr1 | 153591514 | - |
| 5UTR-5UTR | ENST00000312753 | ENST00000491177 | GNRHR2 | chr1 | 145515189 | - | S100A13 | chr1 | 153591514 | - |
Top |
FusionProtFeatures for GNRHR2_S100A13 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| GNRHR2 | S100A13 |
| Lectin that binds to various sugars: galactose > mannose= fucose > N-acetylglucosamine > N-acetylgalactosamine(PubMed:10224141). Acts as a chemoattractant, probably involved inthe regulation of cell migration (PubMed:28301481).{ECO:0000269|PubMed:10224141, ECO:0000269|PubMed:28301481}. | Plays a role in the export of proteins that lack asignal peptide and are secreted by an alternative pathway. Bindstwo calcium ions per subunit. Binds one copper ion. Binding of onecopper ion does not interfere with calcium binding. Required forthe copper-dependent stress-induced export of IL1A and FGF1. Thecalcium-free protein binds to lipid vesicles containingphosphatidylserine, but not to vesicles containingphosphatidylcholine (By similarity). {ECO:0000250,ECO:0000269|PubMed:12746488, ECO:0000269|PubMed:20863990}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for GNRHR2_S100A13 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for GNRHR2_S100A13 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| GNRHR2 | S100A13 | IL1A, PHYHIP, SYT1, FGF1, STK4, THOC7, NUDT21, IGBP1, IRF9, PCYT1A, VAT1, CEP57, S100A13, PLEKHF2, MGST3, SNRNP27, SPRY2, SDC2, KIFAP3, CCL5 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for GNRHR2_S100A13 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Tgene | S100A13 | Q99584 | DB00768 | Olopatadine | Protein S100-A13 | small molecule | approved |
| Tgene | S100A13 | Q99584 | DB01164 | Calcium Chloride | Protein S100-A13 | small molecule | approved |
| Tgene | S100A13 | Q99584 | DB11093 | Calcium Citrate | Protein S100-A13 | small molecule | approved |
| Tgene | S100A13 | Q99584 | DB11348 | Calcium Phosphate | Protein S100-A13 | small molecule | approved |
| Tgene | S100A13 | Q99584 | DB01025 | Amlexanox | Protein S100-A13 | small molecule | approved|investigational |
| Tgene | S100A13 | Q99584 | DB01373 | Calcium | Protein S100-A13 | small molecule | approved|nutraceutical |
Top |
RelatedDiseases for GNRHR2_S100A13 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|